Literature DB >> 15755813

Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells.

Toshie Iwai1, Takashi Kudo, Risa Kawamoto, Tomomi Kubota, Akira Togayachi, Toru Hiruma, Tomoko Okada, Toru Kawamoto, Kyoei Morozumi, Hisashi Narimatsu.   

Abstract

The core 3 structure of the O-glycan, GlcNAcbeta1-3GalNAcalpha1-Ser/Thr, an important precursor in the biosynthesis of mucin-type glycoproteins, is synthesized by beta1,3-N-acetylglucosaminyltransferase 6 (beta3Gn-T6; core 3 synthase). We generated an anti-beta3Gn-T6 mAb (G8-144 mAb) and performed immunohistochemical analyses. In normal stomach and colon, beta3Gn-T6 was strongly expressed in the Golgi region of epithelia. In contrast, its expression was markedly down-regulated in gastric and colorectal carcinomas. Tissue specimens from a familial adenomatous polyposis patient showed a clear correlation between the down-regulation of beta3Gn-T6 expression and the degree of dysplasia/neoplasia. In vitro, the level of beta3Gn-T6 transcript was increased according to the differentiation of Caco-2 cells. These results suggested that the expression of beta3Gn-T6 is closely regulated during differentiation and dedifferentiation. beta3Gn-T6 would be a useful marker for distinguishing between benign adenomas and premalignant lesions. HT1080 FP-10 cells stably transfected with the beta3Gn-T6 gene showed a decrease in the core 1 structure, Galbeta1,3GalNAcalpha1-Ser/Thr, probably due to competition between the core 1 synthase and core 3 synthase. The migration activity of the transfectants was markedly lower than that of mock transfectants in vitro, and lung metastasis after i.v. injection of the transfectants into nude mice was significantly suppressed. These findings indicated that the core structures of O-glycans are profoundly involved in the metastatic capacity of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15755813      PMCID: PMC555466          DOI: 10.1073/pnas.0407983102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  Glycosylation defining cancer malignancy: new wine in an old bottle.

Authors:  Senitiroh Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-30       Impact factor: 11.205

2.  New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase.

Authors:  T Nagatsu; M Hino; H Fuyamada; T Hayakawa; S Sakakibara
Journal:  Anal Biochem       Date:  1976-08       Impact factor: 3.365

3.  Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen.

Authors:  Yan Zhang; Hiroko Iwasaki; Han Wang; Takashi Kudo; Timothy B Kalka; Thierry Hennet; Tomomi Kubota; Lamei Cheng; Niro Inaba; Masanori Gotoh; Akira Togayachi; Jianming Guo; Hisashi Hisatomi; Kazuyuki Nakajima; Shoko Nishihara; Mitsuru Nakamura; Jamey D Marth; Hisashi Narimatsu
Journal:  J Biol Chem       Date:  2002-10-28       Impact factor: 5.157

Review 4.  Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives.

Authors:  S Hakomori
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

5.  Glycosphingolipids as tumor-associated and differentiation markers.

Authors:  S Hakomori; R Kannagi
Journal:  J Natl Cancer Inst       Date:  1983-08       Impact factor: 13.506

6.  Functional conservation of subfamilies of putative UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases in Drosophila, Caenorhabditis elegans, and mammals. One subfamily composed of l(2)35Aa is essential in Drosophila.

Authors:  Tilo Schwientek; Eric P Bennett; Carlos Flores; John Thacker; Martin Hollmann; Celso A Reis; Jane Behrens; Ulla Mandel; Birgit Keck; Mireille A Schäfer; Kim Haselmann; Roman Zubarev; Peter Roepstorff; Joy M Burchell; Joyce Taylor-Papadimitriou; Michael A Hollingsworth; Henrik Clausen
Journal:  J Biol Chem       Date:  2002-03-29       Impact factor: 5.157

7.  Expression of carbohydrate antigen 19-9 and stage-specific embryonic antigen 1 in nontumorous and tumorous epithelia of the human colon and rectum.

Authors:  E Gong; S Hirohashi; Y Shimosato; M Watanabe; Y Ino; S Teshima; S Kodaira
Journal:  J Natl Cancer Inst       Date:  1985-09       Impact factor: 13.506

8.  Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation.

Authors:  C R Boland; C K Montgomery; Y S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

9.  Oligosaccharide structures of human colonic mucin.

Authors:  D K Podolsky
Journal:  J Biol Chem       Date:  1985-07-15       Impact factor: 5.157

10.  Mucin synthesis. UDP-GlcNAc:GalNAc-R beta 3-N-acetylglucosaminyltransferase and UDP-GlcNAc:GlcNAc beta 1-3GalNAc-R (GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase from pig and rat colon mucosa.

Authors:  I Brockhausen; K L Matta; J Orr; H Schachter
Journal:  Biochemistry       Date:  1985-04-09       Impact factor: 3.162

View more
  60 in total

1.  A Tn antigen binding lectin from Myrsine coriacea displays toxicity in human cancer cell lines.

Authors:  Andrea Medeiros; Nora Berois; Marcelo Incerti; Sylvie Bay; Laura Franco Fraguas; Eduardo Osinaga
Journal:  J Nat Med       Date:  2012-05-30       Impact factor: 2.343

Review 2.  Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.

Authors:  Seema Chugh; Vinayaga S Gnanapragassam; Maneesh Jain; Satyanarayana Rachagani; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2015-08-28

3.  A validated collection of mouse monoclonal antibodies to human glycosyltransferases functioning in mucin-type O-glycosylation.

Authors:  Catharina Steentoft; Zhang Yang; Shengjun Wang; Tongzhong Ju; Malene B Vester-Christensen; María F Festari; Sarah L King; Kelley Moremen; Ida S B Larsen; Christoffer K Goth; Katrine T Schjoldager; Lars Hansen; Eric P Bennett; Ulla Mandel; Yoshiki Narimatsu
Journal:  Glycobiology       Date:  2019-08-20       Impact factor: 4.313

Review 4.  Two opposing roles of O-glycans in tumor metastasis.

Authors:  Shigeru Tsuboi; Shingo Hatakeyama; Chikara Ohyama; Minoru Fukuda
Journal:  Trends Mol Med       Date:  2012-03-16       Impact factor: 11.951

5.  Mining the O-glycoproteome using zinc-finger nuclease-glycoengineered SimpleCell lines.

Authors:  Catharina Steentoft; Sergey Y Vakhrushev; Malene B Vester-Christensen; Katrine T-B G Schjoldager; Yun Kong; Eric Paul Bennett; Ulla Mandel; Hans Wandall; Steven B Levery; Henrik Clausen
Journal:  Nat Methods       Date:  2011-10-09       Impact factor: 28.547

6.  Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor.

Authors:  Shingo Hatakeyama; Atsushi Kyan; Hayato Yamamoto; Akiko Okamoto; Naoki Sugiyama; Yuichiro Suzuki; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Shigeyuki Yamada; Hideo Saito; Yoichi Arai; Minoru Fukuda; Chikara Ohyama
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

Review 7.  Sweetening the pot: adding glycosylation to the biomarker discovery equation.

Authors:  Penelope M Drake; Wonryeon Cho; Bensheng Li; Akraporn Prakobphol; Eric Johansen; N Leigh Anderson; Fred E Regnier; Bradford W Gibson; Susan J Fisher
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

8.  Glycosylation potential of human prostate cancer cell lines.

Authors:  Yin Gao; Vishwanath B Chachadi; Pi-Wan Cheng; Inka Brockhausen
Journal:  Glycoconj J       Date:  2012-07-28       Impact factor: 2.916

Review 9.  Recent insights into the biological roles of mucin-type O-glycosylation.

Authors:  E Tian; Kelly G Ten Hagen
Journal:  Glycoconj J       Date:  2008-08-10       Impact factor: 2.916

10.  Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells.

Authors:  Yuh-Jin Liang; Yao Ding; Steven B Levery; Marlin Lobaton; Kazuko Handa; Sen-itiroh Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.